Literature DB >> 9042066

Measuring health-related quality of life in rhinitis.

E F Juniper1.   

Abstract

Patients with rhinitis are bothered both by the nasal symptoms themselves and by associated symptoms such as headache and fatigue. The combination can produce quite severe impairment of day-to-day physical, emotional, occupational, and social functioning and can cause emotional distress. This breadth of impairment of health-related quality of life in patients with rhinitis is often not recognized and is sometimes trivialized by some health care professionals. One of the aims of treating patients with rhinitis must be to ensure that all individual patient problems are recognized and treated appropriately. Several studies now show that correlations between conventional nasal symptom-severity diaries and health-related quality of life are only weak to moderate. Therefore, to get an overall picture of a patient's health status, it is essential to measure quality of life. Genetic health-status questionnaires are able to compare burden of illness across different medical conditions, but they are often not responsive enough to small but clinically important changes in patients' quality of life. As a result, we have seen the emergence of disease-specific instruments for rhinitis that have strong measurement properties and that are much more sensitive to these changes. Most clinical trials in rhinitis now include a measure of health-related quality of life as a primary outcome, and many clinicians are incorporating quality of life into routine clinical assessments.

Entities:  

Mesh:

Year:  1997        PMID: 9042066     DOI: 10.1016/s0091-6749(97)90000-2

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  24 in total

Review 1.  The economic burden of allergic rhinitis: a critical evaluation of the literature.

Authors:  Shelby D Reed; Todd A Lee; Douglas C McCrory
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control.

Authors:  Robert A Nathan; Anand A Dalal; Richard H Stanford; Eli O Meltzer; Michael Schatz; Jennifer Derebery; Matthew Mintz; Michelle A Thompson; Dana B Dibenedetti
Journal:  Patient       Date:  2010-06-01       Impact factor: 3.883

3.  The effects of phototherapy on quality of life in allergic rhinitis cases.

Authors:  Cemal Cingi; Aytekin Yaz; Hamdi Cakli; Erkan Ozudogru; Cem Kecik; Cengiz Bal
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-22       Impact factor: 2.503

4.  Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study).

Authors:  D J Costa; P Marteau; M Amouyal; L K Poulsen; E Hamelmann; M Cazaubiel; B Housez; S Leuillet; M Stavnsbjerg; P Molimard; S Courau; J Bousquet
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

Review 5.  [Quality of life. An important parameter in respiratory tract diseases].

Authors:  I Kirchberger
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

Review 6.  Impact of sleep as a specific marker of quality of life in allergic rhinitis.

Authors:  Vanesa González-Núñez; Antonio Luís Valero; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2013-04       Impact factor: 4.806

7.  Clinical efficacy and safety of a combined loratadine-betamethasone oral solution in the treatment of severe pediatric perennial allergic rhinitis.

Authors:  Teolinda Mendoza de Morales; Francis Sánchez
Journal:  World Allergy Organ J       Date:  2009-04       Impact factor: 4.084

Review 8.  Mometasone furoate. A review of its intranasal use in allergic rhinitis.

Authors:  S V Onrust; H M Lamb
Journal:  Drugs       Date:  1998-10       Impact factor: 9.546

Review 9.  Clinical and pathogenetic characteristics of pregnancy rhinitis.

Authors:  Eva K Ellegård
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

10.  Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.

Authors:  Friedrich Horak
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.